| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,546 |
10,039 |
$526K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
9,422 |
8,276 |
$393K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,233 |
7,553 |
$307K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
14,824 |
6,630 |
$197K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,710 |
9,468 |
$141K |
| 92567 |
|
12,173 |
10,534 |
$117K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,588 |
1,410 |
$110K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,782 |
5,034 |
$109K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,023 |
916 |
$78K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
931 |
860 |
$65K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,928 |
1,931 |
$43K |
| 87807 |
|
1,556 |
1,393 |
$16K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
279 |
271 |
$15K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
169 |
167 |
$14K |
| 86580 |
|
1,671 |
1,605 |
$12K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
191 |
167 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,738 |
4,158 |
$5K |
| 83655 |
|
527 |
437 |
$4K |
| 81002 |
|
1,476 |
1,293 |
$4K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
28 |
28 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
84 |
81 |
$2K |
| 99382 |
|
15 |
15 |
$1K |
| 99050 |
|
97 |
86 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
20 |
15 |
$783.20 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,001 |
4,400 |
$598.71 |
| 92552 |
|
85 |
73 |
$574.92 |
| 90461 |
|
270 |
187 |
$462.07 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
169 |
158 |
$409.16 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
24 |
17 |
$223.89 |
| 90686 |
|
685 |
650 |
$215.81 |
| 90734 |
|
89 |
71 |
$154.72 |
| 36415 |
Collection of venous blood by venipuncture |
2,485 |
2,224 |
$99.75 |
| 81025 |
|
13 |
12 |
$93.99 |
| 90715 |
|
15 |
13 |
$62.39 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
24 |
17 |
$0.85 |
| 90620 |
|
13 |
13 |
$0.00 |
| 90696 |
|
12 |
12 |
$0.00 |
| 90710 |
|
68 |
63 |
$0.00 |
| 90670 |
|
98 |
94 |
$0.00 |
| 90649 |
|
95 |
89 |
$0.00 |
| 90633 |
|
58 |
57 |
$0.00 |